HCM
NVO

Heathbridge Capital Management’s Novo Nordisk NVO Stock Holding History

Heathbridge Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-117,950
Closed -$8.19M – 28
2025
Q1 		$8.19M Sell
117,950
-2,250
-2% -$186K 3.33% 17
2024
Q4 		$10.3M Buy
+120,200
New +$13M 4.11% 13

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Heathbridge Capital Management's NVO Position: Q2 2025 in Review

Heathbridge Capital Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 117,950 shares — an estimated $8.19M sold.

Heathbridge Capital Management first reported a position in NVO in Q4 2024 and held it in 2 quarters. The position peaked at $10.3M in Q4 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Heathbridge Capital Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Heathbridge Capital Management sold 117,950 Novo Nordisk shares in Q2 2025, an estimated $8.19M.
  • Heathbridge Capital Management first reported a position in Novo Nordisk in Q4 2024 and held it in 2 quarters.
  • Heathbridge Capital Management's Novo Nordisk position peaked at $10.3M in Q4 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Heathbridge Capital Management's 13F filing for Q2 2025, filed 23 Jul 2025.